Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV-1 infection
|
94 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2002 | 2014 | |||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2001 | 2011 | |||||
Bladder Neoplasm
|
281 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2010 | 2012 | |||||
Carcinoma of bladder
|
309 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2010 | 2012 | |||||
Malignant neoplasm of prostate
|
1082 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2012 | 2015 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2010 | 2012 | |||||
Malignant Neoplasms
|
1641 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2013 | |||||
Neoplasm Metastasis
|
327 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||
Parkinson Disease
|
990 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2013 | |||||
Prostate carcinoma
|
1168 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2012 | 2015 | |||||
Acquired Immunodeficiency Syndrome
|
42 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||
Anthracosis
|
37 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Aortic Aneurysm, Abdominal
|
90 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Breast Carcinoma
|
2793 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Carotid Artery Plaque
|
3 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Carotid Atherosclerosis
|
79 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Coronary Artery Disease
|
1577 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||
Hepatitis C
|
347 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
HER2-negative breast cancer
|
18 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
HER2-positive carcinoma of breast
|
26 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Hypertensive disease
|
1085 | 0.623 | 0.600 | 2 | 136115750 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2003 | 2003 |